179 related articles for article (PubMed ID: 33902008)
1. The lncRNA GATA3-AS1/miR-495-3p/CENPU axis predicts poor prognosis of breast cancer via the PLK1 signaling pathway.
Lin S; Zhao M; Lv Y; Mao G; Ding S; Peng F
Aging (Albany NY); 2021 Apr; 13(10):13663-13679. PubMed ID: 33902008
[TBL] [Abstract][Full Text] [Related]
2. LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.
Liu SQ; Zhou ZY; Dong X; Guo L; Zhang KJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32538432
[TBL] [Abstract][Full Text] [Related]
3. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancer.
Lou W; Ding B; Zhong G; Du C; Fan W; Fu P
Aging (Albany NY); 2019 Dec; 11(23):11416-11439. PubMed ID: 31794425
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
Liu X; Yao W; Xiong H; Li Q; Li Y
Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
[TBL] [Abstract][Full Text] [Related]
6. Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p.
Shin CH; Lee H; Kim HR; Choi KH; Joung JG; Kim HH
Cell Death Differ; 2017 Nov; 24(11):1861-1871. PubMed ID: 28708135
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MAFG-AS1 Upregulates Polo-Like Kinase-1 by Sponging miR-505 to Promote Gastric Adenocarcinoma Cell Proliferation.
Fu Y; Wen J; Li X; Gong M; Guo Z; Wang G
Crit Rev Eukaryot Gene Expr; 2021; 31(5):27-32. PubMed ID: 34591387
[TBL] [Abstract][Full Text] [Related]
8. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
9. Abnormal Expression of Centromere Protein U Is Associated with Hepatocellular Cancer Progression.
Yu Y; Chen X; Zhang W; Liu J
Biomed Res Int; 2021; 2021():4051192. PubMed ID: 34957303
[TBL] [Abstract][Full Text] [Related]
10. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA NNT-AS1 affects progression of breast cancer through miR-142-3p/ZEB1 axis.
Li Y; Lv M; Song Z; Lou Z; Wang R; Zhuang M
Biomed Pharmacother; 2018 Jul; 103():939-946. PubMed ID: 29710510
[TBL] [Abstract][Full Text] [Related]
12. The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches.
Arabpour M; Layeghi SM; Bazzaz JT; Naghizadeh MM; Majidzadeh-A K; Shakoori A
Hum Cell; 2021 Jul; 34(4):1227-1243. PubMed ID: 34043149
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
14. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
[TBL] [Abstract][Full Text] [Related]
15. LINC01234 promoted malignant behaviors of breast cancer cells via hsa-miR-30c-2-3p/CCT4/mTOR signaling pathway.
Tang C; Li C; Chen C; Chen T; Zhu J; Sun M; Wang P; Han C
Taiwan J Obstet Gynecol; 2024 Jan; 63(1):46-56. PubMed ID: 38216268
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-875-3p alleviates the progression of colorectal cancer via negatively regulating PLK1 level.
Li SS; Zhu HJ; Li JY; Tian LM; Lv DM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1126-1133. PubMed ID: 32096168
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway.
Meng X; Ma J; Wang B; Wu X; Liu Z
J Physiol Biochem; 2020 May; 76(2):301-315. PubMed ID: 32157498
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines.
Guan MM; Rao QX; Huang ML; Wang LJ; Lin SD; Chen Q; Liu CH
Med Sci Monit; 2019 Oct; 25():8131-8141. PubMed ID: 31663517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
